BIOMAT Database Logo BIOMAT Database Logo

Immunosuppressive therapy in opsoclonus-myoclonus ataxia syndrome associated with paravertebral neuroblastoma. 2020

A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
Departamento de Neurología, Unidad Médica de Alta Especialidad, Hospital de Pediatría "Dr. Silvestre FrenkFreund", Centro Médico Nacional Siglo XXI; Instituto Mexicano del Seguro Social (I.M.S.S.), Ciudad de México, México.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007223 Infant A child between 1 and 23 months of age. Infants
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D010372 Pediatrics A medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence.
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
Rituximab for opsoclonus myoclonus ataxia syndrome associated with neuroblastoma.
February 2014, Indian journal of pediatrics,
A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
[Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
July 2014, Zhonghua er ke za zhi = Chinese journal of pediatrics,
A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
Opsoclonus-myoclonus-ataxia syndrome associated with dengue.
February 2015, Parkinsonism & related disorders,
A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome.
June 2009, Neuropediatrics,
A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
"Pediatrician's Approach to Recognizing Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome".
September 2023, Clinical pediatrics,
A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
Opsoclonus-myoclonus, ataxia, and coincident neuroblastoma.
April 1995, The Journal of pediatrics,
A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
Enigmatic entities: opsoclonus myoclonus ataxia syndrome linked to neuroblastoma.
January 2018, The Lancet. Child & adolescent health,
A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
[Ataxia-opsoclonus-myoclonus syndrome].
January 1981, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
Opsoclonus myoclonus ataxia syndrome.
January 2018, Neurology India,
A Castañón-González, and E Barragán-Pérez, and G Hernández-Pliego, and J C López-Valdés
Opsoclonus, myoclonus, ataxia and occult neuroblastoma (neuroblastoma-encephalopathy).
June 1974, The Western journal of medicine,
Copied contents to your clipboard!